• FirefoxInstall the new Firefox »
  •  Dow Down 0.47% Nasdaq Down 0.56%

    Mylan, Inc. (MYL)

    -NasdaqGS
    55.44 Down 2.45(4.24%) Mar 3, 4:00PM EST
    Add to Portfolio
    Prev Close:57.89
    Open:56.76
    Bid:55.35 x 100
    Ask:56.39 x 300
    1y Target Est:60.33
    Beta:0.83
    Earnings Date:Apr 29 - May 4 (Est.)
    Day's Range:55.00 - 57.20
    52wk Range:44.74 - 59.60
    Volume:6,511,135
    Avg Vol (3m):3,209,900
    Market Cap:20.75B
    P/E (ttm):24.00
    EPS (ttm):2.31
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    MYLDown 4.24%20.75B
    ACTDown 0.36%78.87B
    TEVADown 1.22%48.10B

    Key Statistics

    Forward P/E (1 yr):12.02
    P/S (ttm):2.91
    Ex-Dividend Date:27-Jun-07

    Analysts

    Annual EPS Est (Dec-15) :4.13
    Quarterly EPS Est (Mar-15) :0.74
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):1.04

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Mylan Inc., a pharmaceutical company, develops, licenses, manufactures, markets, and distributes generic, branded generic, and specialty pharmaceuticals worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback